NCT06289023View on ClinicalTrials.gov

HA-WBRT-SIB for Brain Metastasis of Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

January 1, 2020

Study Completion Date

December 31, 2022

Conditions
Lung NeoplasmBrain MetastasesSimultaneous Integrated BoostHippocampal AvoidanceCognitive Function
Interventions
RADIATION

HA-WBRT-SIB

A total dose of 30-36 Gy delivered in 18-20 fractions to the whole brain (CTV), while the dose to the GTV were boosted to 44 Gy-52 Gy in 18-20 fractions, five times a week.

Trial Locations (1)

Unknown

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

NCT06289023 - HA-WBRT-SIB for Brain Metastasis of Lung Cancer | Biotech Hunter | Biotech Hunter